may 22nd semaglutide On February 21, 2025, the FDA announced that semaglutide, the active ingredient in Ozempic and Wegovy, is no longer considered in shortage, signaling an improvement in national supply. As a result, compounding The Wild East of semaglutide

My experience on Rybelsus doesnt match the GLP-1 narrative Ive read about.

Understanding these changes helps you track your health progress and ensures your prescriber has complete information for dose adjustments

Persistent numbness, marked pain, colour changes, or warmth suggests irritation or a rare nerve/skin issue switch sites and ask your clinician to review your technique

But what do we need to consider when using them in older age

It's only 215 calories and 20g protein, keeping me full and on track without feeling deprived

Compare NHS prescription charges with private treatment costs, understand eligibility criteria, and find strategies to access affordable GLP-1 therapy for diabetes and weight management.